These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8277142)

  • 1. Severity of depression and response to fluoxetine.
    Pande AC; Sayler ME
    Int Clin Psychopharmacol; 1993; 8(4):243-5. PubMed ID: 8277142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.
    Emslie GJ; Rush AJ; Weinberg WA; Kowatch RA; Hughes CW; Carmody T; Rintelmann J
    Arch Gen Psychiatry; 1997 Nov; 54(11):1031-7. PubMed ID: 9366660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
    Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
    Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine in tricyclic refractory major depressive disorder.
    Beasley CM; Sayler ME; Cunningham GE; Weiss AM; Masica DN
    J Affect Disord; 1990 Nov; 20(3):193-200. PubMed ID: 2148340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.
    Beasley CM; Dornseif BE; Bosomworth JC; Sayler ME; Rampey AH; Heiligenstein JH; Thompson VL; Murphy DJ; Masica DN
    BMJ; 1991 Sep; 303(6804):685-92. PubMed ID: 1833012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response patterns of depressed outpatients with and without melancholia: a double-blind, placebo-controlled trial of fluoxetine versus placebo.
    Heiligenstein JH; Tollefson GD; Faries DE
    J Affect Disord; 1994 Mar; 30(3):163-73. PubMed ID: 8006243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course of psychomotor agitation during pharmacotherapy of depression: analysis from double-blind controlled trials with fluoxetine.
    Tollefson GD; Sayler ME
    Depress Anxiety; 1996-1997; 4(6):294-311. PubMed ID: 9166658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
    Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
    CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression.
    Feighner JP; Boyer WF; Merideth CH; Hendrickson GG
    Int Clin Psychopharmacol; 1989 Apr; 4(2):127-34. PubMed ID: 2663975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.
    Feighner JP
    J Clin Psychiatry; 1985 Sep; 46(9):369-72. PubMed ID: 3897204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern analysis of antidepressant response to fluoxetine.
    Fieve RR; Goodnick PJ; Peselow ED; Barouche F; Schlegel A
    J Clin Psychiatry; 1986 Nov; 47(11):560-2. PubMed ID: 3533909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind trial of fluoxetine, 20 mg, and placebo in out-patients with DSM-III-R major depression and melancholia.
    Heiligenstein JH; Tollefson GD; Faries DE
    Int Clin Psychopharmacol; 1993; 8(4):247-51. PubMed ID: 8277143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine in the prevention of depressive recurrences: a double-blind study.
    Gilaberte I; Montejo AL; de la Gandara J; Perez-Sola V; Bernardo M; Massana J; Martin-Santos R; Santiso A; Noguera R; Casais L; Perez-Camo V; Arias M; Judge R;
    J Clin Psychopharmacol; 2001 Aug; 21(4):417-24. PubMed ID: 11476126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind study of fluoxetine and maprotiline in the treatment of major depression.
    de Jonghe F; Ravelli DP; Tuynman-Qua H
    Pharmacopsychiatry; 1991 Mar; 24(2):62-7. PubMed ID: 1852793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind multi-centre trial of fluoxetine and dothiepin in major depressive illness. South Wales Antidepressant Drug Trial Group.
    Int Clin Psychopharmacol; 1988 Jan; 3(1):75-81. PubMed ID: 3282004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: an updated meta-analysis.
    Beasley CM; Koke SC; Nilsson ME; Gonzales JS
    Clin Ther; 2000 Nov; 22(11):1319-30. PubMed ID: 11117656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P; Hardison CD
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia.
    Hellerstein DJ; Yanowitch P; Rosenthal J; Samstag LW; Maurer M; Kasch K; Burrows L; Poster M; Cantillon M; Winston A
    Am J Psychiatry; 1993 Aug; 150(8):1169-75. PubMed ID: 8328559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.
    Joyce PR; Mulder RT; Luty SE; Sullivan PF; McKenzie JM; Abbott RM; Stevens IF
    Aust N Z J Psychiatry; 2002 Jun; 36(3):384-91. PubMed ID: 12060188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.